← SynDRA
XAV-939
SynDRA canonical compound SYN0086815 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TNKS |
|---|
| Mechanism of action | Tankyrase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MTOR
- PIK3CA
- PIK3CB
- PRKDC
- ATR
- PIK3CG
- YES1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- 284028-89-3
- NVP-XAV939
- XAV939
- NVP-XAV-939
- CHEBI:62878
- G2MY39VR77
- RefChem:195217
- DTXCID20320459
- XAV-939 (GMP)
- XAV 939; NVP-XAV 939;
- KLGQSVMIPOVQAX-UHFFFAOYSA-N
- XAV
- MFCD16879017
- 3kr8
- 3uh4
- Maybridge3_005018
- MLS006012021
- orb1307281
- SCHEMBL7783488
- SCHEMBL15315468
- SCHEMBL15565864
- SCHEMBL29411302
- XAV939,XAV-939
- GLXC-03267
- HMS1445E02
- HMS3414D07
- HMS3648B17
- HMS3654O16
- HMS3678D07
- HMS3743E05
- EX-A1760
- XAV-939?
- BDBM50188594
- BDBM50318567
- EBC-11320
- EBC-84065
- HB0660
- HY-15147G
Look up XAV-939 in the interactive SynDRA portal →